Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF Balance Sheet Health
Financial Health criteria checks 5/6
Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF has a total shareholder equity of $210.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $267.0M and $56.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$149.55k |
Equity | US$210.65m |
Total liabilities | US$56.39m |
Total assets | US$267.04m |
Recent financial health updates
No updates
Recent updates
No updates
Financial Position Analysis
Short Term Liabilities: PBE's short term assets ($56.3M) do not cover its short term liabilities ($56.4M).
Long Term Liabilities: PBE has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: PBE is debt free.
Reducing Debt: PBE has not had any debt for past 5 years.
Debt Coverage: PBE has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: PBE has no debt, therefore coverage of interest payments is not a concern.